Skip to main content
Caplight Logo









Rostra Therapeutics

Rostra Therapeutics

Private
GlasgowHealthcare & Life Scienceshttps://www.rostratx.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$191,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Rostra Therapeutics is a biopharmaceutical company that develops novel anti-infective medicines based on its proprietary Strathclyde Minor Groove Binders (S-MGBs) platform to treat serious infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoveryanti-infective medicinesantimicrobial resistanceAMRminor groove bindersS-MGBsinvasive fungal infectionssmall-molecule drugsbiotech startupdrug pipelinepre-clinical developmentuniversity spin-outantibiotic alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rostra Therapeutics Comparables

Compare Rostra Therapeutics with similar companies based on industry and business-model similarity.

Rostra Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Angel Therapeutics
81%
MyxoBiomedical
79%
NovaBiotics Ltd
76%

Rostra Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
GrantNov 13, 2024
GrantJun 14, 2022

Key People

Founding team and executive leadership

David Findlay

Co-founder and CEO

Founding Team

Rostra Therapeutics Investors

Notable investors and investment history

Rostra Therapeutics investors
InvestorRounds
University of ExeterGrant
Scottish EDGEGrant
Cystic Fibrosis TrustGrant
Medicines Discovery CatapultGrant
LifeArcGrant
CF AMR SyndicateGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    Monthly visitors increased 119% MoM, reaching 1.9K.

  • Nov 19, 2025

    Received grant funding from the University of Exeter.

Rostra Therapeutics Filings

Explore SEC and related filing metadata, where available.

Rostra Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rostra Therapeutics's valuation, stock price, and market status.

Is Rostra Therapeutics a public or private company?

Rostra Therapeutics is a private company.

What is the current stock price of Rostra Therapeutics?

Rostra Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Rostra Therapeutics worth (valuation)?

Valuation information for Rostra Therapeutics is not publicly available.

Can I buy Rostra Therapeutics stock?

Rostra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rostra Therapeutics's last funding round?

Funding round information for Rostra Therapeutics is not publicly available.

Who are the main investors in Rostra Therapeutics?

Investor information for Rostra Therapeutics is not publicly disclosed.

Will Rostra Therapeutics IPO soon?

No public IPO plans have been announced for Rostra Therapeutics.

How can I track Rostra Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rostra Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGlasgow
Employee Range3
Year Founded2022
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?